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Reducing Stigma-Driven Health Disparities in People Living 
with HIV (PLWH): A Literature Review 
 
Abstract 
 
Introduction: Research has found that HIV-related stigma has numerous 
negative impacts on the lives of people living with HIV 
(PLWH). Although there are more resources than ever dedicated to 
HIV/AIDS efforts, stigma continues to be a major factor challenging the 
prevention and treatment of HIV today. Understanding the impacts of 
stigma on health outcomes and quality of life in PLWH is essential to 
address the global HIV epidemic and reduce health disparities. 
 
Search Strategy: We conducted a secondary meta-analysis of existing 
research that discussed and evaluated the impacts of HIV-related stigma and 
discrimination on PLWH. We searched the following databases for peer-
reviewed articles: EBSCO Host, Cumulative Index of Nursing and Allied 
Health Literature (CINAHL), and PubMed. We also obtained reports from 
Centers for Disease Control (CDC), Food and Drug Administration (FDA), 
Office of the High Commissioner for Human Rights (OHCHR), World 
Health Organization (WHO), and the Joint United Nations Programme on 
HIV/AIDS (UNAIDS). 
 
Results: Our review of the literature revealed that HIV-related stigma is a 
socially constructed global phenomenon that reflects social and cultural 
tradition. Most current stigma-reduction interventions are designed to 
address individual-level stigma (symbolic stigma). While this has 
contributed to improvements in individual attitudes towards PLWH, 
interventions at the individual level alone do not address the macro-level 
attitudes and societal norms that influence individual ideals and behaviors.  
 
Conclusion: Findings in the literature review suggest that because of the 
pervasiveness of HIV-related stigma globally, addressing stigma is 
imperative to the HIV response. It also suggests that interventions that 
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address stigma at the structural level and target multiple domains might 
have a more profound impact on HIV-related health outcomes. 
 
 Keywords: HIV stigma, health disparities, social determinants of 
health, stigma reduction 
 
Background 
 In the United States, more than 1.2 million people are living with 
HIV. Among those at risk, men who have sex with men (MSM), African-
Americans, Hispanics, and those who are economically disadvantaged bear 
a disproportionate burden of HIV (CDC, 2016). Despite the availability of 
more resources than ever before dedicated to HIV/AIDS efforts, stigma, 
discrimination, blame, and denial are still several key factors that continue 
to challenge the prevention and treatment of HIV in 2016. Former head of 
the World Health Organization’s Global Program on AIDS, Jonathan Mann, 
labeled stigma as the “third epidemic” related to the HIV/AIDS outbreak 
(Pulerwitz, Michaelis,Weiss, Brown, & Mahendra, 2010). Although it is 
widely acknowledged that stigma poses a major barrier to effective HIV 
prevention and treatment, efforts to reduce stigma are still relegated to the 
bottom of HIV/AIDS program priorities (Mahajan et al., 2008). Current 
evidence and growing bodies of literature might contribute to shifting HIV 
intervention priorities as they reveal the impacts of stigma reduction on 
overall health outcomes in people living with HIV (PLWH). 
 HIV-related stigma builds upon preexisting prejudices that work to 
reinforce existing social inequalities that maintain the relationships of 
power and control (Maluwa, Aggleton, & Parker, 2002). The intersection of 
discrimination and stigma in these different facets work simultaneously to 
perpetuate inequality and support a power hierarchy that disadvantages 
individuals based on gender, minority status, socioeconomic standing, 
occupation, HIV status, and more (Maluwa, Aggleton, & Parker, 2002; 
Melton, 2011). Under General Comment No. 14, the United Nations 
Committee on Economic, Social, and Cultural Rights, states that the right 
to health is “closely related to and dependent upon the realization of other 
human rights,” including human dignity, education, non-discrimination, 
and equality (Committee on Economic, Social, and Cultural Rights CESCR, 
3
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2000). Although some of these aspects are beyond the scope of this 
research, they underscore the role that underlying determinants such as 
discrimination and stigma play on the quality and implementation of health 
care. The Centers for Disease Control acknowledges that a significant 
health disparity exists among populations in which HIV is rampant, and 
successful HIV prevention is dependent upon addressing these disparities 
and achieving health equity (2015).  
 
Search Strategy 
 The search strategy and criteria included terms such as “HIV-related 
stigma,” “HIV,” “stigma” and “HIV stigma and health.” Databases accessed 
for peer-reviewed articles included EBSCO Host, Cumulative Index of 
Nursing and Allied Health Literature (CINAHL), and PubMed. Grey 
literature such as program reports, evaluation reports, and policy documents 
were obtained from the California Department of Health Care Services, 
Centers for Disease Control (CDC), Food and Drug Administration (FDA), 
Office of the High Commissioner for Human Rights (OHCHR), World 
Health Organization (WHO), Google, and the Joint United Nations 
Programme on HIV/AIDS (UNAIDS). Inclusion criteria included 
publications in English and studies of any design from any country that 
contained stigma and/or discrimination related to HIV. Studies discussing 
stigma and discrimination outside of the HIV context were excluded.  
 
Drivers of Stigma 
 HIV-related stigma is a global phenomenon that is highly reflective 
of social and cultural mores, tradition, and values (Chambers et al., 2015; 
Gagnon, 2015). It is deeply embedded in social processes and manifests in 
varying forms on interpersonal, institutional, community, and legislative 
levels (Pulerwitz et al., 2010). HIV-related stigma is often compounded 
with other stigmatizing determinants such as homelessness, history of drug 
use, occupation (e.g., sex work), poverty, race, and sexual orientation 
(Maluwa, Aggleton, & Parker, 2002; Pulerwitz et al., 2010). It is overtly 
displayed through interpersonal interactions manifesting as symbolic 
stigma, or nuanced under laws, policies, and general practices as structural 
stigma.  
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Symbolic Stigma 
 Symbolic stigma within the healthcare context is experienced 
through interactions with healthcare providers who have negative 
perceptions of PLWH (Gagnon, 2015). It is evident in the way that PLWH 
are treated and perceived in healthcare settings. Examples of symbolic 
stigma are negative stereotypes associated with particular groups (e.g., 
MSM, drug users, sex workers), mode of transmission (e.g., drug use, 
unprotected sex), and categorization (e.g., labeling as infectious, dangerous, 
deviant, guilty) (Gagnon, 2015). Symbolic stigma in healthcare settings can 
have pervasive repercussions on patients’ overall health. Some impacts of 
HIV-related stigma include incorrect knowledge about HIV transmission, 
decreased effectiveness of prevention efforts with refusal of HIV testing, 
reduced adherence to biomedical treatment, refusal to participate in health 
promotion behaviors (e.g., regular clinic visits, condom use), nondisclosure 
to partners, and lack of social support (Pulerwitz et al., 2010; Stangl, Lloyd, 
Brady, Holland, & Baral, 2013; Wagner, McShane, Hart, & Margolese, 
2016).  
 
Structural Stigma 
 Structural stigma includes stigma that is manifested in policies, 
structures, and discourse that inadvertently result in stigmatizing or 
discriminatory practices towards PLWH (Gagnon, 2015). This type of 
policy is exemplified in the U.S. Federal Drug Administration’s 
recommendations for blood donation of MSM. In 1985, the FDA issued a 
recommendation prohibiting any male who has ever had sex with another 
man from donating blood as a measure to reduce risk of HIV transmission 
by blood and blood products. Almost three decades later, studies evaluating 
this deferral policy indicated that the recommendations for indefinite 
deferral of MSM were suboptimal. This ultimately led to changes in 
recommendations for blood donation. Under current guidelines, the deferral 
policy for MSM is 12 months from the most recent sexual contact with 
another man (U.S. Department of Health and Human Services, Food and 
Drug Administration, 2015). However, according to the FDA, 
“establishments may voluntarily elect more stringent donor deferral criteria 
than those required or recommended by the FDA” (U.S. Department of 
Health and Human Services, Food and Drug Administration, 2015, para. 4). 
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Allowing establishments to individually determine who may or may not be 
eligible to donate blood despite current recommendations will continue to 
reinforce institutionalized stigma by form of exclusion. In addition, these 
policies do not reflect best current scientifically based evidence. Other 
manifestations of structural stigma are presented in systematic risk 
management and fear management across health care settings.  
 
Risk Management 
 Through the language of risk, PLWH are subject to structural 
stigma. Structural stigma varies from symbolic stigma in that it is often 
embedded in institutions and is felt beyond individual interactions. An 
example of this is in risk management and organizational policies. Risk 
management procedures and organizational policies such as precautionary 
segregation of PLWH, although initially intended to protect patients, such 
as from opportunistic infections, could stigmatize them through 
demarcation and separation from the general public (Chambers et al., 2015; 
Gagnon, 2015). Additional issues related to risk management within the 
clinical setting include confidentiality violations such as public display of 
infection control markings, use of scheduling policies (e.g., scheduling 
HIV-positive patients last in the day to reduce potential of risk exposure to 
other clients), and disclosure of patient HIV status among healthcare 
workers outside of a need to know (Gagnon, 2015). This may pose a 
problem in multiple ways. Not only can it create an environment that fosters 
stigmatizing attitudes, it also compromises the protection and confidential 
handling of patient protected health information required under the Health 
Insurance Portability and Accountability Act of 1996 (California 
Department of Health Care Services, 2015).  
 
Fear Management 
 Although the lack of education or misperceptions regarding the 
mode of transmission of the HIV virus has been frequently attributed to 
HIV-related stigma within healthcare settings, research findings indicate 
that affective dimensions (i.e., emotions) can be a strong driver of HIV-
related stigma in the context of healthcare (Chambers et al., 2015). For 
example, even practitioners knowledgeable of HIV transmission risks 
report fear of casual contact with HIV-positive patients not because of a 
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cognitive knowledge gap relating to modes of transmission of the virus, but 
because of existing prejudices that influence the affective dimensions that 
overpower rational decision-making (Chambers et al., 2015). This finding 
further reinforces the social and cultural influences that contribute to HIV-
related stigma.  
 
Stigma Reduction 
 In a systematic review of 48 studies involving stigma-reduction 
interventions, Stangl et al. (2013) found that the most common types of 
interventions were targeted at a single socioecological level (n = 41) (Table 
1), the most common being at the individual level (n = 27). Less common 
types of interventions were community level interventions (n = 7), 
organizational (n = 3), interpersonal (n = 2), and public policy level 
interventions (n = 2). Only seven studies intervened at multiple 
socioecological levels (Stangl et al., 2013). Of all studies reviewed, Stangl 
et al. (2013) found that 79 percent of studies reported statistically significant 
reductions in stigma.   
 
Table 1 
Socio-ecological levels targeted in 48 studies (Stangl et al., 2013) 
Individual 27 
Community  7 
Organizational 3 
Interpersonal 2 
Public Policy 2 
Multiple targeted levels 7 
 
 Overall, the reviewed studies reveal the overwhelming complexity 
and multidimensional nature of HIV-related stigma. The findings indicate 
the significance of addressing both symbolic and structural stigma, and thus, 
suggest the need for interventions to reduce both interpersonal and 
structural forms of HIV-related stigma.  
 
Results 
 Findings suggest that HIV-related stigma is a socially constructed 
phenomenon that is representative of social and cultural traditions and 
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norms. It is often compounded with other stigmatized conditions such as 
racial and ethnic minority status, socioeconomic standing, and sexual 
minority status (Maluwa, Aggleton, & Parker, 2002; Pulerwitz et al., 2010; 
Chambers et al., 2015; Gagnon, 2015). This reveals that determinants such 
as racial and ethnic background, income, and class play a role in stigma that 
many PLWH encounter. Problematic stereotypes about people of color, the 
poor, LGBTQ, drug users, sex workers, etc. contribute to negative 
perceptions about PLWH. Therefore, such determinants must be taken into 
account when examining appropriate responses and interventions for 
addressing HIV, particularly in those who fall into these categories. Because 
HIV-related stigma permeates social structures and reflects dominant 
culture ideology, it remains salient today and continues to present a 
challenge in the HIV/AIDS response.  
 Current research indicates that there has been considerable progress 
in reducing stigma and negative attitudes toward PLWH as a result of 
stigma-reduction interventions (Stangl et al., 2013; Clair, Daniel, & 
Lamont, 2016).  A majority of research surrounding HIV-related stigma 
examines the impacts of stigma on an interpersonal level, with a focus on 
individual attitudes and behaviors towards PLWH. Moreover, most current 
stigma-reduction interventions have targeted individual-level stigma, which 
has contributed to improved individual attitudes towards PLWH. However, 
interventions that address structural level stigma that target macro-level 
attitudes such as those toward minority groups, the poor, and those who 
participate in perceived socially deviant behaviors, cultural norms, and 
tradition remain relatively understudied. 
 
Analysis 
In order to gain a greater understanding of the impacts of stigma on 
PLWH, it may be helpful to think about HIV-related stigma as a systemic 
problem. Stigma can be real, perceived, overtly expressed, or subtly 
conveyed. Regardless of the mode of delivery, it affects all who are faced 
with stigmatizing experiences. 
 In 1943, Abraham Maslow described a hierarchy of human needs 
that falls into five stages: physiological needs (e.g. air, food, drink, shelter, 
warmth, etc.), safety and security needs (e.g., protection from elements, 
security, order, law, stability, etc.), love and belonging needs 
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(e.g., friendship, intimacy, affection and love), self-
esteem needs (e.g., achievement, mastery, independence, status, 
dominance, prestige, self-respect, respect from others), and self-
actualization needs (e.g., realizing personal potential, self-fulfillment, 
seeking personal growth and peak experiences. He argued that the basic 
physiological needs must first be satisfied before any higher level needs can 
be met, followed respectively by safety and security, love and belonging, 
self-esteem, and self-actualization. Thinking about HIV stigma in relation 
to Maslow's hierarchy of needs, one can argue that Western societal values 
relegate stigma into the realm of higher level needs (i.e., self-esteem). Using 
Maslow's hierarchy as a framework might explain why HIV-related stigma 
remains at the bottom of HIV/AIDS priorities. While it can be argued that 
stigma appropriately falls into the category of self-esteem needs, it can also 
be said that stigma impacts certain aspects of physiological and safety needs 
through allocation of resources and lack of access to essential components 
in these categories. Our findings indicate that HIV-related stigma can 
contribute to or detract from fundamental human physiological and safety 
and security needs; thus, we argue that stigma remains a pertinent barrier to 
addressing the HIV epidemic and remains a pressing aspect in the HIV 
response. 
 
Discussion 
 While there have been significant improvements in reducing 
individual stigmatizing attitudes and behaviors toward PLWH, existing 
stigma-reduction interventions rarely address structural stigmas. Emerging 
themes in the literature emphasize the need for collective efforts and a 
multidimensional approach that involves social and cultural paradigm shifts 
(see Table 2).  Clair et. al (2016) suggest that social actors play a significant 
role in shaping cultural constructions surrounding stigmatized groups, and 
these constructions must be changed using the influence of these social 
actors. Others suggest the importance of increasing awareness through 
education, support, and legislation (Thapa, Hannes, Cargo, Buve, & Mathei, 
2015; Clair et. al, 2016).  
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Table 2 
Comparison of proposed stigma-reduction intervention strategies  
 
Clair, Daniel & Lamont, 
2016 
Thapa et al., 2015 Chambers et al., 2015  
Change cultural 
constructions surrounding 
stigmatized groups by 
using social actors (i.e., 
public health and medical 
experts, legal experts, 
social science and policy 
experts, media and 
journalists, social 
movement activists, firms 
and workplaces) to 
remove blame and create 
equivalencies in PLWH 
and the general public. 
Create awareness using 
HIV-specific information-
based written or verbal 
communication and 
education. 
A multidimensional 
approach involving 
healthcare settings, and 
also address discrimination 
within institutional culture 
as well as factors that foster 
HIV-related stigma at the 
individual, environmental, 
and societal levels.  
 Provide psychosocial, 
clinical, socio-economic, 
and family and community 
support to people living 
with or at risk for 
HIV/AIDS. 
 
 Implement interventions 
that incorporate HIV-
specific legislation that 
protects and respects the 
human rights of people 
living with HIV, and 
develop normative 
behavior by increasing 
community organizing and 
actions. 
 
 
 
Conclusions 
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 Findings in this research suggest that 1) stigma must be a priority in 
the HIV response, and 2) both individual-level and structural-level stigma 
must be addressed in order to decrease overall HIV-related stigma. While 
interventions addressing symbolic stigma have shown considerable 
progress, there remain significant gaps and challenges in understanding and 
encompassing stigma on a larger scale. Due to the complexity and multi-
faceted nature of HIV-related stigma, it is imperative to also address the 
structural factors that foster public stigmatizing attitudes and behaviors such 
as negative perceptions of minority groups including people of color, 
LGBTQ, and people of lower socioeconomic status. Further, it is crucial to 
examine the impacts of factors and conditions that compound these stigmas. 
Findings suggest that incorporating both symbolic and structural stigma and 
understanding the compounding effects of other stigmas (i.e., occupation, 
poverty, homelessness, race, sexual orientation, etc.) and structural 
determinants could have a more drastic impact by addressing the root of 
HIV-related stigma. To fully understand the scope of the problem, it may 
be helpful to gain a better understanding of stigma from the perspectives 
and experiences of PLWH. Future research evaluating the impacts of stigma 
that juxtapose the perceptions of stigma from PLWH who belong to 
minority groups (i.e., racial/ethnic minorities, LGBTQ) and PLWH from 
majority groups (i.e., non-racial minorities, heterosexual) could relay 
invaluable information that may guide potential stigma-reduction 
interventions and ultimately contribute to addressing stigma-driven health 
disparities in PLWH. 
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